Astrazeneca Pharma India Ltd. (ASTRAZEN) Share Price Hits Fresh 52-Week Low
- August 25, 2026
- Posted by: Harsh Piplani
- Category: News
Astrazeneca Pharma India Ltd. fell 0.37% to Rs 7,193.20 after hitting a fresh 52-week low of Rs 7,174.05. Market capitalisation stood at Rs 18,050.13 crore.
Astrazeneca Pharma India Ltd. Share Price was at Rs 7,193.20 on 25 August 2026 at 1:24 PM IST, down 0.37% from the previous close of Rs 7,220.05, after the stock touched a fresh 52-week low of Rs 7,174.05. The company’s market capitalisation stood at Rs 18,050.13 crore, placing the move firmly on the radar of investors tracking Healthcare names and Stocks in News.
The verified data confirms the price event clearly: Astrazeneca Pharma India Ltd. Share Price Today slipped below prior trading levels, opened at Rs 7,298.55, reached the same level as the day’s high, and then declined to a one-year low before trading slightly above that trough. That intraday pattern matters because it shows early prices were not sustained and selling pressure remained visible through the session.
For readers tracking Astrazeneca Pharma India Ltd. Stock News, the present setup is noteworthy for three reasons. First, the stock has printed a fresh yearly low. Second, the move has come even though the absolute day decline was modest at Rs 26.85, showing how closely the stock was already positioned near its 52-week trough. Third, the current valuation and profitability figures offer a mixed fundamental backdrop, which makes Astrazeneca Pharma India Ltd. Share Price News relevant beyond just daily price action. Univest notes that the supplied data confirms the market move, but it does not establish a company-specific catalyst for why the stock is falling today.
Astrazeneca Pharma India Ltd. Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 7,193.2 |
| Previous Close | Rs 7,220.05 |
| Today's Change | Rs -26.85 (-0.37%) |
| Day Open | Rs 7,298.55 |
| Fresh 52-Week Low | Rs 7,174.05 |
| Day High | Rs 7,298.55 |
| Current Volume | 389 |
| Turnover | Rs 0.28 crore |
| Market Capitalisation | Rs 18,050.13 crore |
Astrazeneca Pharma India Ltd. (ASTRAZEN) traded at Rs 7,193.2. versus the previous close of Rs 7,220.05, a fall of 0.37%. The stock opened at Rs 7,298.55, reached Rs 7,298.55, touched Rs 7,174.05. Reported volume was 389.
Astrazeneca Pharma India Ltd. Share Price Today reflects a session where the stock opened strong relative to the eventual low, but intraday weakness pushed it to a fresh 52-week low of Rs 7,174.05. The price remained below the previous close, highlighting a negative daily bias despite a relatively limited percentage decline.
At 1:24 PM IST, Astrazeneca Pharma India Ltd. Share Price stood at Rs 7,193.20 versus the previous close of Rs 7,220.05, a decline of Rs 26.85 or 0.37%. The stock opened at Rs 7,298.55 and that level also marked the day’s high, while the low of Rs 7,174.05 became the new 52-week low and yearly low. This pattern suggests the day’s best price came right at the start of trade, after which the stock moved lower through the session.
Turnover was Rs 0.28 crore and traded volume was 389 shares. For Astrazeneca Pharma India Ltd. Share Price Live watchers, that combination shows a relatively low-activity session in value and quantity terms, but one that still resulted in a fresh 52-week trough. In market terms, the event is significant because even a measured decline can attract attention when it resets the one-year low reference point. That is why Astrazeneca Pharma India Ltd. Share News is now being discussed in the context of 52 Week Low Stocks and Top Losers Today screens, even without a large single-day drawdown.
The next step is to see whether the stock’s current valuation, profitability and sector positioning provide deeper context for this price action.
Astrazeneca Pharma India Ltd. (ASTRAZEN) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 18,050.13 crore |
| P/E Ratio | 49.64x |
| P/B Ratio | 1.9x |
| ROE | -0.78% |
| ROCE | 8.31% |
Astrazeneca Pharma India Ltd. was valued at a P/E ratio of 49.64x, a P/B ratio of 1.9x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.
Profitability and capital efficiency were represented by ROE of -0.78% and ROCE of 8.31%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Benchmark Scope | same sector |
| Company P/E Ratio | 49.64x |
| Benchmark Median P/E | 21.89x |
| Benchmark Average P/E | 49.47x |
| Benchmark P/E Range | 0x to 1,608.25x |
| Company P/B Ratio | 1.9x |
| Benchmark Median P/B | 1.98x |
| Company ROE | -0.78% |
| Benchmark Median ROE | 11.07% |
| Company ROCE | 8.31% |
| Benchmark Median ROCE | 13.35% |
| Company Market Capitalisation | Rs 18,050.13 crore |
| Benchmark Median Market Cap | Rs 140.36 crore |
Astrazeneca Pharma India Ltd. (ASTRAZEN) is classified under sector: Healthcare.
Astrazeneca Pharma India Ltd. (ASTRAZEN) has a P/E ratio of 49.64x, which is above the benchmark median of 21.89x, a difference of +126.77%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Astrazeneca Pharma India Ltd. (ASTRAZEN) has a ROE of -0.78%, which is below the benchmark median of 11.07%, a difference of -107.05%. Astrazeneca Pharma India Ltd. (ASTRAZEN) has a ROCE of 8.31%, which is below the benchmark median of 13.35%, a difference of -37.75%.
Track stocks falling to yearly lows through the Univest 52-week-low screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Ind-Swift Laboratories Ltd. | INDSWFTLAB | 2,864.08 | 49.64 | 1.9 | -0.78 | 8.31 |
| Dishman Carbogen Amcis Ltd. | DCAL | 2,725.67 | 167.99 | 0.41 | -2.89 | -0.26 |
| Dr Agarwals Eye Hospital Ltd. | DRAGARWQ | 2,594.96 | 34.05 | 7.02 | 36.29 | 42.4 |
| Beta Drugs Ltd. | BETA | 2,588.69 | 61.85 | 9.78 | 18.65 | 22.17 |
| Sai Parenteral's Ltd. | SAIPARENT | 2,391.86 | 141.7 | 3 | 13.9 | 12.97 |
Astrazeneca Pharma India Ltd. (ASTRAZEN) has a P/E ratio of 49.64x compared with the displayed peer median of 61.85x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -0.78% compares with a peer median of 13.9% across the companies shown in the table. ROCE stood at 8.31% versus the displayed peer median of 12.97%, providing a capital-efficiency comparison. Astrazeneca Pharma India Ltd. (ASTRAZEN) has a market capitalisation of Rs 18,050.13 crore. Among the 5 peers shown, 0 have a larger market capitalisation.
Why Investors Are Watching Astrazeneca Pharma India Ltd.
The stock is attracting attention because a fresh 52-week low has been confirmed, while valuation, profitability and sector comparisons create a more layered picture than the daily decline alone suggests.
- Fresh price event: Astrazeneca Pharma India Ltd. Share Price hit a new 52-week low of Rs 7,174.05 and was trading at Rs 7,193.20, down 0.37%.
- Intraday weakness: The stock opened at Rs 7,298.55, which was also the day’s high, before moving lower through the session.
- Trading activity: Volume was 389 shares with turnover of Rs 0.28 crore, keeping the stock in market movers and stock updates screens because of the new one-year low.
- Valuation context: The P/E ratio of 49.64 is close to the Healthcare sector average of 49.47, while P/B of 1.90 is below the sector average of 2.70.
- Profitability contrast: ROE of -0.78% and ROCE of 8.31% are below the sector median and average, which adds depth to the current stock analysis.
- Peer positioning: ASTRAZEN has a much larger market cap than the supplied peers, but weaker profitability than most of them.
About Astrazeneca Pharma India Ltd.
Astrazeneca Pharma India Ltd. is a listed company tracked on Univest under the Healthcare sector, and its shares trade under the symbol ASTRAZEN. In the current market update, the stock has drawn attention because it entered the 52 Week Low stocks list after touching Rs 7,174.05 during the session on 25 August 2026.
Within the supplied market data, the company stands out for its scale. Its market capitalisation of Rs 18,050.13 crore is far above the median and average market capitalisation of the 195-company Healthcare benchmark. That makes Astrazeneca Pharma India Ltd. a relatively large listed name within the dataset being compared here.
For readers following Astrazeneca Pharma India Ltd. NSE and Astrazeneca Pharma India Ltd. BSE search interest, the immediate focus is less about broad company background and more about the interaction between price action, valuation and sector positioning. Univest is highlighting the stock because the fresh yearly low, combined with a large market cap and below-benchmark return ratios, makes it a closely watched counter in today’s Share Market Today and Market News cycle.
Track Astrazeneca Pharma India Ltd. Share Price on Univest
Use Astrazeneca Pharma India Ltd. (ASTRAZEN) live share-price page, Univest 52-week-low screener, Univest market blogs to review live stock data, yearly-low lists and related market analysis.
Investors using Univest can track Astrazeneca Pharma India Ltd. Share Price through live price updates, 52-week levels, valuation ratios, market cap data, peer comparison and sector benchmarks. That gives readers one place to follow Astrazeneca Pharma India Ltd. Share Price Today alongside broader stock analysis.
For users monitoring Astrazeneca Pharma India Ltd. Shareholding Pattern, Astrazeneca Pharma India Ltd. Technical Analysis, Astrazeneca Pharma India Ltd. Fundamental Analysis and Astrazeneca Pharma India Ltd. Share Price Update, Univest helps organise the verified data points that matter most. In this case, the standout markers are the fresh 52-week low, current price of Rs 7,193.20, P/E of 49.64, P/B of 1.90, ROE of -0.78% and ROCE of 8.31%.
As this stock remains in focus, investors may want to monitor whether Astrazeneca Pharma India Ltd. Share Price can stabilise above the 52-week trough, how its valuation compares with peers, and whether future profitability metrics move closer to or further from Healthcare sector benchmarks. That keeps the discussion factual and data-led rather than predictive.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What is the current Astrazeneca Pharma India Ltd. Share Price today?
Ans. Astrazeneca Pharma India Ltd. Share Price was Rs 7,193.20 at 1:24 PM IST on 25 August 2026. The stock was down Rs 26.85, or 0.37%, from the previous close of Rs 7,220.05.
Why is Astrazeneca Pharma India Ltd. Share Price in the news today?
Ans. The stock is in focus because it hit a fresh 52-week low of Rs 7,174.05 during the session. The verified data confirms the price event, though it does not establish any company-specific trigger for the decline.
What was the fresh 52-week low for Astrazeneca Pharma India Ltd.?
Ans. Astrazeneca Pharma India Ltd. touched a fresh 52-week low of Rs 7,174.05 on 25 August 2026. It later traded at Rs 7,193.20, which still kept the stock close to its new one-year trough.
How much did Astrazeneca Pharma India Ltd. Share Price fall today?
Ans. The stock declined by Rs 26.85 on the day, which translates into a fall of 0.37% from the previous close. The move was modest in percentage terms but significant because it created a fresh yearly low.
What does today’s intraday price action show for Astrazeneca Pharma India Ltd.?
Ans. The stock opened at Rs 7,298.55, which was also the day’s high, and then slipped to a low of Rs 7,174.05. That pattern indicates early prices were not sustained during the trading session.
What is the market capitalisation of Astrazeneca Pharma India Ltd.?
Ans. Astrazeneca Pharma India Ltd. had a market capitalisation of Rs 18,050.13 crore in the supplied data. That is far above the Healthcare sector benchmark median of Rs 140.36 crore and average of Rs 477.14 crore.
Is Astrazeneca Pharma India Ltd. expensive compared with the Healthcare sector?
Ans. Its P/E ratio of 49.64 is almost in line with the Healthcare sector average of 49.47, but above the sector median of 21.89. Its P/B ratio of 1.90 is slightly below the sector median of 1.98.
How does Astrazeneca Pharma India Ltd. compare with its peers?
Ans. Astrazeneca Pharma India Ltd. is much larger by market cap than the supplied peers, but its ROE and ROCE are weaker than most of them. Its P/E of 49.64 sits around the middle of the peer range.
What should investors monitor next for Astrazeneca Pharma India Ltd. Share Price?
Ans. Investors can monitor whether the stock stays near or moves away from the fresh 52-week low of Rs 7,174.05, while also tracking valuation ratios, profitability metrics and its position against Healthcare sector benchmarks.
